Molina Healthcare (NYSE:MOH) updated its FY 2019 earnings guidance on Monday. The company provided earnings per share (EPS) guidance of $9.25-9.75 for the period, compared to the Thomson Reuters consensus estimate of $9.29. The company issued revenue guidance of $16.3-16.3 billion, compared to the consensus revenue estimate of $17.21 billion.
Several equities analysts recently commented on the stock. ValuEngine raised shares of Molina Healthcare from a sell rating to a hold rating in a research report on Wednesday, January 2nd. Jefferies Financial Group upgraded shares of Molina Healthcare from a hold rating to a buy rating and increased their price objective for the company from $152.00 to $169.00 in a research note on Tuesday, November 13th. Zacks Investment Research raised shares of Molina Healthcare from a hold rating to a strong-buy rating and set a $155.00 target price on the stock in a report on Tuesday, October 23rd. Morgan Stanley increased their price objective on shares of Molina Healthcare from $178.00 to $184.00 and gave the stock an overweight rating in a report on Thursday, October 18th. Finally, Mitsubishi UFJ Financial Group upgraded shares of Molina Healthcare from a neutral rating to an overweight rating in a research report on Tuesday, January 8th. One analyst has rated the stock with a sell rating, seven have given a hold rating, seven have assigned a buy rating and one has assigned a strong buy rating to the company. The stock has an average rating of Buy and an average target price of $141.15.
MOH traded up $0.19 during trading hours on Monday, reaching $137.09. The company’s stock had a trading volume of 905,900 shares, compared to its average volume of 780,008. The company has a current ratio of 1.40, a quick ratio of 1.40 and a debt-to-equity ratio of 0.78. Molina Healthcare has a 52 week low of $71.07 and a 52 week high of $154.06. The stock has a market cap of $8.55 billion, a PE ratio of 244.80, a price-to-earnings-growth ratio of 1.18 and a beta of 1.67.
In other Molina Healthcare news, Director Charles Z. Fedak sold 3,795 shares of the firm’s stock in a transaction that occurred on Monday, November 19th. The stock was sold at an average price of $120.74, for a total value of $458,208.30. Following the completion of the sale, the director now owns 18,464 shares of the company’s stock, valued at $2,229,343.36. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Ronna Romney sold 200 shares of the firm’s stock in a transaction that occurred on Monday, December 3rd. The shares were sold at an average price of $141.23, for a total value of $28,246.00. The disclosure for this sale can be found here. Insiders sold 5,395 shares of company stock valued at $671,770 over the last quarter. Corporate insiders own 0.65% of the company’s stock.
ILLEGAL ACTIVITY WARNING: “Molina Healthcare (MOH) Releases FY 2019 Earnings Guidance” was first published by American Banking News and is the sole property of of American Banking News. If you are reading this piece on another website, it was illegally stolen and reposted in violation of US & international copyright & trademark laws. The correct version of this piece can be read at https://www.americanbankingnews.com/2019/02/11/molina-healthcare-moh-releases-fy-2019-earnings-guidance.html.
About Molina Healthcare
Molina Healthcare, Inc provides Medicaid-related solutions to meet the health care needs of low-income families and individuals; and to assist state agencies in their administration of the Medicaid program in the United States. It operates through three segments: Health Plans, Molina Medicaid Solutions, and Other.
Further Reading: What factors cause inflation to rise?
Receive News & Ratings for Molina Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Molina Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.